These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3079775)

  • 1. Regional distribution of human growth hormone-releasing hormone in the human hypothalamus by radioimmunoassay.
    Leidy JW; Robbins RJ
    J Clin Endocrinol Metab; 1986 Feb; 62(2):372-8. PubMed ID: 3079775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Localization of growth hormone-releasing hormone in the human hypothalamus and pituitary stalk.
    Werner H; Okon E; Fridkin M; Koch Y
    J Clin Endocrinol Metab; 1986 Jul; 63(1):47-50. PubMed ID: 2872227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The growth hormone (GH)-axis of GH receptor/binding protein gene-disrupted and metallothionein-human GH-releasing hormone transgenic mice: hypothalamic neuropeptide and pituitary receptor expression in the absence and presence of GH feedback.
    Peng XD; Park S; Gadelha MR; Coschigano KT; Kopchick JJ; Frohman LA; Kineman RD
    Endocrinology; 2001 Mar; 142(3):1117-23. PubMed ID: 11181526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoreactive corticotropin-releasing hormone, growth hormone-releasing hormone, somatostatin, and peptide histidine methionine are present in adrenal pheochromocytomas, but not in extra-adrenal pheochromocytoma.
    Sasaki A; Yumita S; Kimura S; Miura Y; Yoshinaga K
    J Clin Endocrinol Metab; 1990 Apr; 70(4):996-9. PubMed ID: 1969422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presence of growth hormone-releasing hormone-like immunoreactivity in human tumors: characterization of immunological and biological properties.
    Losa M; Wolfram G; Mojto J; Schopohl J; Spiess Y; Huber R; Müller OA; von Werder K
    J Clin Endocrinol Metab; 1990 Jan; 70(1):62-8. PubMed ID: 2104630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of the growth hormone-releasing hormone gene and its peptide product in the rat ovary.
    Bagnato A; Moretti C; Ohnishi J; Frajese G; Catt KJ
    Endocrinology; 1992 Mar; 130(3):1097-102. PubMed ID: 1537276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization and localization of an immunoreactive growth hormone-releasing hormone precursor form in normal and tumoral human anterior pituitaries.
    Rauch C; Li JY; Croissandeau G; Berthet M; Peillon F; Pagesy P
    Endocrinology; 1995 Jun; 136(6):2594-601. PubMed ID: 7750482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth hormone-releasing factor immunoreactivity in the hypothalamus and cortex of the rat: in vivo and in vitro studies.
    Leidy JW; Robbins RJ
    Endocrinology; 1988 Apr; 122(4):1652-7. PubMed ID: 3126041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoreactive growth hormone-releasing hormone in rat placenta.
    Meigan G; Sasaki A; Yoshinaga K
    Endocrinology; 1988 Aug; 123(2):1098-102. PubMed ID: 2899497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. L-dopa stimulates release of hypothalamic growth hormone-releasing hormone in humans.
    Chihara K; Kashio Y; Kita T; Okimura Y; Kaji H; Abe H; Fujita T
    J Clin Endocrinol Metab; 1986 Mar; 62(3):466-73. PubMed ID: 3080462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptide histidine methionine may be a prolactin-releasing hormone in humans.
    Sasaki A; Sato S; Shinkawa O; Go M; Otsuka T; Sugawara A; Shimizu Y; Murakami O; Hanew K; Andoh N
    J Clin Endocrinol Metab; 1988 Jun; 66(6):1202-7. PubMed ID: 3131380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of antagonists of growth hormone-releasing hormone (GHRH) on GH and insulin-like growth factor I levels in transgenic mice overexpressing the human GHRH gene, an animal model of acromegaly.
    Kovacs M; Kineman RD; Schally AV; Zarandi M; Groot K; Frohman LA
    Endocrinology; 1997 Nov; 138(11):4536-42. PubMed ID: 9348175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoreactive growth hormone-releasing factor in human stalk median eminence.
    Lin HD; Bollinger J; Ling N; Reichlin S
    J Clin Endocrinol Metab; 1984 Jun; 58(6):1197-9. PubMed ID: 6427265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction and activity of a novel GHRH analog, Pro-Pro-hGHRH(1-44)-Gly-Gly-Cys.
    Tang SS; Zhang JH; Du MH; Wu J; Liu JJ
    Acta Pharmacol Sin; 2004 Nov; 25(11):1464-70. PubMed ID: 15525469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyrotropin-releasing hormone in rat pituitary stalk blood and hypothalamus: studies with high performance liquid chromatography.
    Sheward WJ; Harmar AJ; Fraser HM; Fink G
    Endocrinology; 1983 Nov; 113(5):1865-9. PubMed ID: 6414807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age-related changes in growth hormone (GH)-releasing hormone and somatostatin neurons in the hypothalamus and in GH cells in the anterior pituitary of female mice.
    Kuwahara S; Kesuma Sari D; Tsukamoto Y; Tanaka S; Sasaki F
    Brain Res; 2004 Oct; 1025(1-2):113-22. PubMed ID: 15464751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regional distribution of rat growth hormone releasing factor-like immunoreactivity in rat hypothalamus.
    Kita T; Chihara K; Abe H; Minamitani N; Kaji H; Kodama H; Kashio Y; Okimura Y; Fujita T; Ling N
    Endocrinology; 1985 Jan; 116(1):259-62. PubMed ID: 3917250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intimate associations between the endogenous opiate systems and the growth hormone-releasing hormone system in the human hypothalamus.
    Olsen J; Peroski M; Kiczek M; Grignol G; Merchenthaler I; Dudas B
    Neuroscience; 2014 Jan; 258():238-45. PubMed ID: 24239719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between the morphological evaluation of the pituitary and the growth hormone (GH) response to GH-releasing hormone Plus arginine in children and adults with congenital hypopituitarism.
    Maghnie M; Salati B; Bianchi S; Rallo M; Tinelli C; Autelli M; Aimaretti G; Ghigo E
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1574-9. PubMed ID: 11297586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction in adiposity affects the extent of afferent projections to growth hormone-releasing hormone and somatostatin neurons and the degree of colocalization of neuropeptides in growth hormone-releasing hormone and somatostatin cells of the ovine hypothalamus.
    Iqbal J; Manley TR; Ciofi P; Clarke IJ
    Endocrinology; 2005 Nov; 146(11):4776-85. PubMed ID: 16081637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.